100% results for the Moderna Corona Vaccine administered to children of the age group 12-17!
Posted on: 26/May/2021 12:58:07 PM
Moderna, a USA Company, has informed that once children of the age group 12-17 were administered with the Moderna vaccine against the raging resurgent coronavirus, IT HAS SHOWN 100% SUCCESS ON PREVENTION!
As a challenge to the raging resurgent coronavirus pandemic which has been plaguing all countries in the world almost affecting every sector of survival including economy, production, education, etc., and plunging a majority of citizens across the world in despair, several countries have taken up the invention of a suitable vaccine for this monstrous disease!
In this effort, Moderna, a company in the United States of America has produced an mRNA-1273 vaccine for the coronavirus pandemic which is being administered to US citizens.
The relieving news is that the coronavirus has been presently kept under check in the USA when the vaccination of citizens is in progress!
In this scenario, Moderna has come up with the announcement that once the children of the age group 12-17 have been administered with 2 doses of the Moderna vaccine, it has been established that the immunity among these vaccinated children increased and has yielded 100% success!
The Managing Director of Moderna, Stephen Bansal shared in this regard:
“Two-thirds of a total of 3732 children in the age group 12-17 were administered with 2 doses of the Moderna vaccine against the coronavirus. It was established that these children were not affected by corona! The first dose establishes an efficiency of 93% success! The children administered with 2 doses will be monitored for the next 1-year period! We will be applying for increasing the extent of administration of the Moderna Vaccine among the above age group with the US Food and Medicine Regulation Council.”
Approval to administer Pfizer’s Bio-n-Tech vaccine for the children of age group, 12-15 was obtained recently!
Both the companies, Pfizer & Moderna, have been organising a trial-run administering their vaccines among the children aged 6 months-old to 11-years old!
